Henning Schacht/Getty Images
The German vaccine rollout has been complicated by people avoiding that particular jab.
It seems part of a trend, reported by Insider, of people seeking the Pfizer-BioNTech shot instead.
Officials in Germany are defending AstraZeneca s coronavirus vaccine and pushing back against people who are avoiding it with the hope of getting a different jab instead.
Regulators have approved both the shot developed by AstraZeneca and Oxford University and the shot developed by Pfizer and the German company BioNTech, but differing efficacy rates from clinical trials appear to have driven many to try to hold out for a Pfizer-BioNTech jab.